CATEGORY
Pharmaceutical Distribution in Europe
Beroe LiVE.Ai™
AI-powered self-service platform for all your sourcing decision needs across 1,200+ categories like Pharmaceutical Distribution in Europe.
Market Data, Sourcing & Supplier Intelligence, and Price & Cost Benchmarking.
Schedule a DemoThe World’s first Digital Market Analyst
Abi, the AI-powered digital assistant brings together data, insights, and intelligence for faster answers to sourcing questions
Abi is now supercharged with GPT4 AI engine. Enjoy the ease of ChatGPT, now on Abi
Pharmaceutical Distribution in Europe Suppliers

Find the right-fit pharmaceutical distribution in europe supplier for your specific business needs and filter by location, industry, category, revenue, certifications, and more on Beroe LiVE.Ai™.
Schedule a Demo


Use the Pharmaceutical Distribution in Europe market, supplier and price information for category strategy creation and Quaterly Business Reviews (QRBs)
Schedule a DemoPharmaceutical Distribution in Europe market report transcript
Regional Market Outlook on Pharmaceutical Distribution in Europe
Pharma Distribution: Austria
Industry is expected to have low bargain and negotiation power, as the pricing mechanism is regulated (average margin of 10 percent) and a consolidated supply market (the top three wholesaler's share is about 77 percent).General practice is to engage with a single wholesaler; however, international manufacturers deal with more than one wholesaler, based on the product portfolio.
Engagement Model
- Single wholesaler for pharmaceutical products is usually adopted
- Majority of the pharmaceutical distribution is through the channel of full-line wholesalers
Distribution Services
- Fee for service is the prevalent pricing model
- Pharmaceutical companies are charged on a fixed commission basis by pharmaceutical wholesalers
Wholesaler/Distribution Margin
- The average margin for wholesalers is 10 percent
Sales Incentives
- Non-monetary incentives include training and business education
Pharma Distribution: The Netherlands
Industry is expected to have medium bargain and negotiation power, as the pricing mechanism is negotiable by wholesalers (average margin of 8–12 percent), with a fragmented supply market (the top two wholesaler's share is 40–45 percent).Distribution to hospitals happens through either wholesalers or directly by manufacturers. For direct distribution to hospitals, pharmaceutical companies use wholesaler as logistics service providers.
Engagement Model
- Manufacturers engage with one to two full-line wholesalers for the distribution of products, and the minimum contract period of engagement is three years
- Wholesalers act as a pre-wholesaling distribution partner for direct DTP and hospitals
Distribution Services
- Fee for service is the preferred pricing model
Wholesaler/Distribution Margin
- Wholesaler's margin is unregulated and has no statutory markups on wholesale level, like other EU countries. Wholesalers have entered into a private negotiation with manufacturers
- Wholesaler's margin is 8.5–11.8 percent.
Sales Incentives
- Sales incentives paid to wholesalers is around 10–15 percent of the sales volume
Interesting Reads:
Discover the world of market intelligence and how it can elevate your business strategies.
Learn more about how market intelligence can enable informed decision-making, help identify growth opportunities, manage risks, and shape your business's strategic direction.